Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer

By Chen Dong-Liang   Wang De-Shen   Wu Wen-Jing   Zeng Zhao-Lei   Luo Hui-Yan   Qiu Miao-Zhen   Ren Chao   Zhang Dong-Sheng   Wang Zhi-Qiang   Wang Feng-Hua   Li Yu-Hong   Kang Tie-Bang   Xu Rui-Hua  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 803-811

Oxford University Press

Access to resources Recommend Favorite

“The development tumor model” to study and monitor the entire progression of both primary and metastatic tumors

By Brognaro Enrico  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2219-2230

Springer Publishing Company

Access to resources Recommend Favorite

Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer

By        

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 2837-2844

Spandidos Publications

Access to resources Recommend Favorite

Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy

By Takao Madoka   Yamazaki Kentaro   Boku Narikazu   Ikehara Hisatomo   Hamauchi Satoshi   Tsushima Takahiro   Taniguchi Hiroya   Todaka Akiko   Machida Nozomu   Fukutomi Akira   Onozawa Yusuke   Yasui Hirofumi  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 864-868

Springer Publishing Company

Access to resources Recommend Favorite

The Status of p53 in the Metastatic Progression of Colorectal Cancer

By Heide I.   Thiede C.   Sonntag T.   de Kant E.   Neubauer A.   Jonas S.   Peter F.J.   Neuhaus P.   Herrmann R.   Huhn D.   Rochlitz C.F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1314-1322

Elsevier

Access to resources Recommend Favorite